Coeptis Therapeutics Holdings (COEP) Free Cash Flow (2021 - 2025)
Historic Free Cash Flow for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to -$2.2 million.
- Coeptis Therapeutics Holdings' Free Cash Flow fell 1371.62% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year decrease of 2092.42%. This contributed to the annual value of -$6.6 million for FY2024, which is 815.29% up from last year.
- Coeptis Therapeutics Holdings' Free Cash Flow amounted to -$2.2 million in Q3 2025, which was down 1371.62% from -$2.4 million recorded in Q2 2025.
- In the past 5 years, Coeptis Therapeutics Holdings' Free Cash Flow registered a high of -$59847.0 during Q3 2021, and its lowest value of -$4.2 million during Q4 2021.
- In the last 5 years, Coeptis Therapeutics Holdings' Free Cash Flow had a median value of -$1.7 million in 2023 and averaged -$1.5 million.
- Over the last 5 years, Coeptis Therapeutics Holdings' Free Cash Flow had its largest YoY gain of 7966.46% in 2022, and its largest YoY loss of 162641.74% in 2022.
- Coeptis Therapeutics Holdings' Free Cash Flow (Quarter) stood at -$4.2 million in 2021, then skyrocketed by 79.66% to -$847352.0 in 2022, then tumbled by 99.89% to -$1.7 million in 2023, then rose by 15.19% to -$1.4 million in 2024, then plummeted by 49.82% to -$2.2 million in 2025.
- Its Free Cash Flow stands at -$2.2 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$2.4 million for Q1 2025.